CoChat

Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone

Open access
Lin-Su, Karen, Harbison, Madeleine D., Lekarev, Oksana, Vogiatzi, Maria G., New, Maria I. · 2011 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

CONTEXT: Patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency typically reach a final adult height well below their mid-parental target height. OBJECTIVE: The objective of this study was to examine whether GH alone or in combination with an LHRH analog (LHRHa) improved the final adult height in patients with CAH. DESIGN: The study was a nonrandomized prospective study. SETTING: The study was conducted at two university hospitals in New York City, NY. PARTICIPANTS: Thirty-four patients with CAH treated with GH participated in this study. Nineteen males and 15 females who were predicted to be more than 2 SD below their mid-parental target height or more than 2 SD below the population mean received GH until reaching final adult height. In addition to GH, 27 patients (16 males, 11 females) were also treated with an LHRHa. INTERVENTION: The mean duration of GH treatment was 5.6 ± 1.8 yr in males and 4.5 ± 1.6 yr in females. The mean duration of LHRHa therapy was 3.7 ± 1.7 yr for both sexes. MAIN OUTCOME MEASURES: The primary endpoint variables were final adult height, final height discrepancy, and gain in height. RESULTS: Males reached a significantly higher final adult height (172.0 ± 4.8 cm) than their initial predicted height (162.8 ± 7.7 cm) (P < 0.00001). Females also reached a significantly higher final adult height (162.2 ± 5.3 cm) than initially predicted (151.7 ± 5.2 cm) (P < 0.0000001). Mean gain in height was 9.2 ± 6.7 cm in males and 10.5 ± 3.7 cm in females. CONCLUSION: Our results indicate that GH alone or in combination with LHRHa improves final adult height in patients with CAH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-2699

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. [1]1. New MI, Gertner JM, Speiser PW, Del Balzo P. 1989. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J Endocrinol Invest 12(Suppl 3):91–95 [PubMed] [Google Scholar]
  2. [2]2. Blizzard R. 1999. Adult consequences of pediatric endocrine disease: congenital adrenal hyperplasia. Growth Genet Horm 15:35–41 [Google Scholar]

Cited by

See all 75

Metadata

Authors
Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Cornell University (US)
Corresponding author
New, Maria I.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2011-06
Volume
96
Issue
6
Pages
1710-1717
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2126701770
Cited by
75
References
44
Citations by year
2026: 6 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 2
FWCI
2.21
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (06020)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD000072, HD 00072, Z01HD000072)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
congenital adrenal hyperplasia, 21-hydroxylase deficiency, growth hormone therapy, GnRH analogues, adult height, short stature, height gain, sex differences
MeSH terms
Adolescent, Adrenal Hyperplasia, Congenital, Adult, Body Height, Child, Female, Humans, Gonadotropin-Releasing Hormone, Male, Prospective Studies, Treatment Outcome, Patient Selection, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.